Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba Gigante

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Cancer Therapeutics|February 4, 2012
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonistSandra Liekens, Annelies Bronckaers, Mirella Belleri, et al.
Antiviral Research|January 15, 2019
Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assayAna S Ferreira-Ramos, Changqing Li, Cécilia Eydoux, et al.
Plos One|March 22, 2014
Leishmania infantum EndoG is an endo/exo-nuclease essential for parasite survivalEva Rico, Cristina Oliva, Kilian Jesús Gutierrez, et al.
Antiviral Research|June 17, 2017
Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1Alba Gigante, Asier Gómez-SanJuan, Leen Delang, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Structural Insights into the Mechanisms of Action of Functionally Distinct Classes of Chikungunya Virus Nonstructural Protein 1 InhibitorsKristina Kovacikova, Marina Gorostiola González, Rhian Jones, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Cancer Therapeutics|February 4, 2012
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonistSandra Liekens, Annelies Bronckaers, Mirella Belleri, et al.
Antiviral Research|January 15, 2019
Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assayAna S Ferreira-Ramos, Changqing Li, Cécilia Eydoux, et al.
Plos One|March 22, 2014
Leishmania infantum EndoG is an endo/exo-nuclease essential for parasite survivalEva Rico, Cristina Oliva, Kilian Jesús Gutierrez, et al.
Antiviral Research|June 17, 2017
Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1Alba Gigante, Asier Gómez-SanJuan, Leen Delang, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2021
Structural Insights into the Mechanisms of Action of Functionally Distinct Classes of Chikungunya Virus Nonstructural Protein 1 InhibitorsKristina Kovacikova, Marina Gorostiola González, Rhian Jones, et al.
Pageof 2